| Family Name | Bryostatin |
| Synonyms |
|
| Related Compound Families |
|
| Pathway Type |
PKS - Type I
|
PKS - Type I (trans-AT)
|
PKS - Type II
|
|
| Characteristics |
|
| Pharmacological Identifiers |
Link to PubChem
 | Physiological Effects of Drugs |
| | Immunologic Factors |
|
|  | Adjuvants, Immunologic |
| Therapeutic Uses |
| | Antineoplastic Agents |
|
| Image |
|
| Contributor |
Kyle Conway
Boddy Lab
|
| Clusters |
| Accession # | Organism Lineage | Pathway Type | Description | antiSMASH Link | Contributor | Details |
|
EF032014
|
Proteobacteria
Gammaproteobacteria
Alteromonadales
Alteromonadales genera incertae sedis
Candidatus Endobugula
Proteobacteria (Gamma)
|
PKS - Type I
PKS - Type I (trans-AT)
PKS - Type II
|
Candidatus Endobugula sertula BryS, BryR, BryQ, BryP, BryB, BryC, BryX, BryD, and BryA genes, complete cds.
|
View
|
Kyle Conway
Boddy Lab
|
|
|